Reproductive factors in Hodgkin's disease in women

American Journal of Epidemiology

Volumn 158, Issue 6, 2003, Pages 553-563

  Glaser, Sally L ^a   Clarke, Christina A ^a   Nugent, Rebecca A ^a   Stearns, Cynthia B ^a   Dorfman, Ronald F ^b  

^a NORTHERN CALIFORNIA CANCER CENTER   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Case control studies; Endometriosis; Hodgkin disease; Lactation; Parity

Indexed keywords

HORMONE; ORAL CONTRACEPTIVE AGENT; STEROID HORMONE;

RISK FACTOR; WOMENS HEALTH;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE TIME EFFECT RELATION; ENDOMETRIOSIS; FEMALE; HODGKIN DISEASE; HORMONAL THERAPY; HUMAN; INCIDENCE; INTERVIEW; MAJOR CLINICAL STUDY; NULLIPARA; PARITY; PATIENT SELECTION; POPULATION RESEARCH; RECURRENT DISEASE; REPRODUCTION; RISK; RISK FACTOR; SEX DIFFERENCE; SPONTANEOUS ABORTION; STATISTICAL SIGNIFICANCE; UNITED STATES; UTERUS MYOMA;

ADULT; AGED; BREAST FEEDING; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONTRACEPTIVES, ORAL; FEMALE; HODGKIN DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; INCIDENCE; LEIOMYOMA; LOGISTIC MODELS; MENARCHE; MIDDLE AGED; PARITY; REPRODUCTIVE HISTORY; RISK ASSESSMENT; RISK FACTORS; SAN FRANCISCO;

EID: 0041333883     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/aje/kwg198     Document Type: Article

References (50)

1. Mueller N, Grufferman S. The epidemiology of Hodgkin's disease. In: Mauch PM, Armitage JO, Diehl V, et al, eds. Hodgkin's disease. Philadelphia, PA: Lippincott Williams and Wilkins, 1999:61-77.
2. MacMahon B. Epidemiology of Hodgkin's disease. Cancer Res 1966;26:1189-201.
3. Gutensohn N, Cole P. Childhood social environment and Hodgkin's disease. N Engl J Med 1981;304:135-40.
4. Gutensohn NM. Social class and age at diagnosis of Hodgkin's disease: new epidemiologic evidence for the "two-disease hypothesis." Cancer Treat Rep 1982;66:689-95.
5. Taylor GM, Gokhale DA, Crowther D, et al. Increased frequency of HLA-DPB1*0301 in Hodgkin's disease suggests that susceptibility is HVR-sequence and subtype-associated. Leukemia 1996;10:854-9.
6. Mueller N. Hodgkin's disease. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer epidemiology and prevention. New York, NY: Oxford University Press, 1996:893-919.
7. Grufferman S, Delzell E. Epidemiology of Hodgkin's disease. Epidemiol Rev 1984;6:76-106.
8. Glaser SL. Reproductive factors in Hodgkin's disease in women: a review. Am J Epidemiol 1994; 139:237-46.
9. Westergaard T, Melbye M, Pedersen JB, et al. Birth order, sibship size and risk of Hodgkin's disease in children and young adults: a population-based study of 31 million person-years. Int J Cancer 1997;72:977-81.
10. Glaser SL, Clarke CA, Nugent RA, et al. Social class and risk of Hodgkin's disease in young-adult women in 1988-94. Int J Cancer 2002;98:110-17.
11. Glaser SL, Clarke CA, Steams CB, et al. Age variation in Hodgkin's disease risk factors in older women: evidence from a population-based case-control study. Leuk Lymphoma 2001; 42:997-1004.
12. Percy C, Van Holten V, Muir C. ICD-O: international classification of diseases for oncology. 2nd ed. Geneva, Switzerland: World Health Organization, 1990.
13. Glaser SL, Dorfman RF, Clarke CA. Expert review of the diagnosis and histologic classification of Hodgkin's disease in a population-based cancer registry: interobserver reliability and impact on incidence and survival rates. Cancer 2001;92:218-24.
14. Glaser SL, Stearns CB. Reliability of random-digit dialing screening calls to enumerate an adult female population. Am J Epidemiol 2002;155:972-5.
15. Wingo PA, Ory HW, Layde PM, et al. The evaluation of the data collection process for a multicenter, population-based, case-control design. Am J Epidemiol 1988;128:206-17.
16. Lin SS, Glaser SL, Stewart SL. Reliability of self-reported reproductive factors and childhood social class indicators in a case-control study of women. Ann Epidemiol 2002;12:242-7.
17. Miller AB, Barclay TH, Choi NW, et al. A study of cancer, parity and age at first pregnancy. J Chronic Dis 1980;33:595-605.
18. Kravdal O, Hansen S. Hodgkin's disease: the protective effect of childbearing. Int J Cancer 1993;55:909-14.
19. Lambe M, Hsieh C-C, Tsaih S-W, et al. Childbearing and the risk of Hodgkin's disease. Cancer Epidemiol Biomarkers Prev 1998;7:831-4.
20. Abramson JH, Pridan H, Sacks MI, et al. A case-control study of Hodgkin's disease in Israel. J Natl Cancer Inst 1978;61:307-14.
21. Tavani A, Pregnolato A, La Vecchia C, et al. A case-control study of reproductive factors and risk of lymphomas and myelomas. Leuk Res 1997;21:885-8.
22. Kravdal O, Hansen S. The importance of childbearing for Hodgkin's disease: new evidence from incidence and mortality models. Int J Epidemiol 1996;25:737-43.
23. Franceschi S, Bidoli E, La Vecchia C. Pregnancy and Hodgkin's disease. (Letter). Int J Cancer 1994;58:465-6.
24. Zahm SH, Hoover RN, Fraumeni JF Jr. Hodgkin's disease and parity. (Letter). Int J Cancer 1995;62:362-3.
25. Zwitter M, Zakelj MP, Kosmelj K. A case-control study of Hodgkin's disease and pregnancy. Br J Cancer 1996;73:246-51.
26. Glaser SL, Swartz WG. Time trends in Hodgkin's disease incidence: the role of diagnostic accuracy. Cancer 1990;66:2196-204.
27. Cerhan JR, Habermann TM, Vachon CM, et al. Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: The Iowa Women's Health Study (United States). Cancer Causes Control 2002;13:131-6.
28. Glaser SL, Jarrett RF. The epidemiology of Hodgkin's disease. Bailliere's Clin Haematol 1996;9:401-16.
29. Somigliana E, Vigano P, Vignali M. Endometriosis and unexplained recurrent spontaneous abortion: pathological states resulting from aberrant modulation of natural killer cell function? Hum Reprod Update 1999;5:40-51.
30. Maia DM, Sciarrotta J, Abendroth K, et al. Sex steroid receptors in Hodgkin's disease. Leuk Lymphoma 2000;39:365-71.
31. Giltay EJ, Fonk JC, von Blomberg BM, et al. In vivo effects of sex steroids on lymphocyte responsiveness and immunoglobulin levels in humans. J Clin Endocrinol Metab 2000;85:1648-57.
32. Kincade PW, Medina KL, Smithson G. Sex hormones as negative regulators of lymphopoiesis. Immunol Rev 1994;137:119-34.
33. Kincade PW, Medina KL, Payne KJ, et al. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev 2000;175:128-37.
34. Medina KL, Strasser A, Kincade PW. Estrogen influences the differentiation, proliferation, and survival of early B-lineage precursors. Blood 2000;95:2059-67.
35. Baker DA, Salvatore W, Milch PO. Effect of low-dose oral contraceptives on natural killer cell activity. Contraception 1989;39:119-24.
36. Kamada M, Irahara M, Maegawa M, et al. Transient increase in the levels of T-helper 1 cytokines in postmenopausal women and the effects of hormone replacement therapy. Gynecol Obstet Invest 2001;52:82-8.
37. Matera L, Mori M, Geuna M, et al. Prolactin in autoimmunity and antitumor defence. J Neuroimmunol 2000;109:47-55.
38. Rier SE, Yeaman GR. Immune aspects of endometriosis: relevance of the uterine mucosal immune system. Semin Reprod Endocrinol 1997;15:209-20.
39. Medina KL, Smithson G, Kincade PW. Suppression of B lymphopoiesis during normal pregnancy. J Exp Med 1993;178: 1507-15.
40. Moseley JM, Gillespie MT. Parathyroid hormone-related protein. Crit Rev Clin Lab Sci 1995;32:299-343.
41. McCauley LK, Rosol TJ, Merryman JI, et al. Parathyroid hormone-related protein binding to human T-cell lymphotropic virus type I-infected lymphocytes. Endocrinology 1992;130: 300-6.
42. Nelson RA, Levine AM, Bernstein L. Reproductive factors and risk of intermediate- or high-grade B-cell non-Hodgkin's lymphoma in women. J Clin Oncol 2001;19:1381-7.
43. Cerhan JR, Vachon CM, Habermann TM, et al. Hormone replacement therapy and risk of non-Hodgkin lymphoma and chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev 2002;11:1466-71.
44. Christiansen OB. Epidemiological, immunogenetic and immunotherapeutic aspects of unexplained recurrent miscarriage. Dan Med Bull 1997;44:396-424.
45. Christiansen OB. The possible role of classical human leukocyte antigens in recurrent miscarriage. Am J Reprod Immunol 1999;42:110-15.
46. Klitz W, Aldrich CL, Fildes N, et al. Localization of predisposition to Hodgkin disease in the HLA class II region. Am J Hum Genet 1994;54:497-505.
47. Leyendecker G, Kunz G, Noe M, et al. Endometriosis: a dysfunction and disease of the archimetra. Hum Reprod Update 1998;4:752-62.
48. Parazzini F, Vercellini P, Panazza S, et al. Risk factors for adenomyosis. Hum Reprod 1997;12:1275-9.
49. Sangi-Haghpeykar H, Poindexter AN 3rd. Epidemiology of endometriosis among parous women. Obstet Gynecol 1995;85: 983-92.
50. Lamb K, Nichols TR. Endometriosis: a comparison of associated disease histories. Am J Prev Med 1986;2:324-9.